GoodRx Holdings, Inc.

NasdaqGS:GDRX 주식 보고서

시가총액: US$1.6b

GoodRx Holdings 관리

관리 기준 확인 2/4

GoodRx Holdings CEO는 Scott Wagner, Apr2023 에 임명되었습니다 의 임기는 1.58 년입니다. 총 연간 보상은 $ 10.14M, 5% 로 구성됩니다. 5% 급여 및 95% 보너스(회사 주식 및 옵션 포함). 는 $ 1.85M 가치에 해당하는 회사 주식의 0.11% 직접 소유합니다. 1.85M. 경영진과 이사회의 평균 재임 기간은 각각 2.5 년과 7.3 년입니다.

주요 정보

Scott Wagner

최고 경영자

US$10.1m

총 보상

CEO 급여 비율5.0%
CEO 임기1.6yrs
CEO 소유권0.1%
경영진 평균 재임 기간2.5yrs
이사회 평균 재임 기간7.3yrs

최근 관리 업데이트

Recent updates

GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Shares May Have Run Too Fast Too Soon

Oct 29
GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Shares May Have Run Too Fast Too Soon

GoodRx: The Tide Is Turning The Wrong Way (Rating Downgrade)

Oct 26

GoodRx Holdings: Failing To Gain Much Traction

Oct 08

GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

Sep 22
GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

GoodRx Q2 Earnings Preview

Jul 31

GoodRx Holdings (NASDAQ:GDRX) Could Easily Take On More Debt

Jul 12
GoodRx Holdings (NASDAQ:GDRX) Could Easily Take On More Debt

GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 30% Price Boost Is Out Of Tune With Revenues

Jun 09
GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 30% Price Boost Is Out Of Tune With Revenues

Returns On Capital At GoodRx Holdings (NASDAQ:GDRX) Paint A Concerning Picture

Jun 06
Returns On Capital At GoodRx Holdings (NASDAQ:GDRX) Paint A Concerning Picture

GoodRx: Encouraging Profit Stabilization (Rating Upgrade)

May 28

GoodRx Holdings: Large TAM Continues To Support Growth

Mar 20

GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Mar 07
GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Is GoodRx Holdings, Inc. (NASDAQ:GDRX) Trading At A 24% Discount?

Mar 01
Is GoodRx Holdings, Inc. (NASDAQ:GDRX) Trading At A 24% Discount?

GoodRx Holdings (NASDAQ:GDRX) Has A Rock Solid Balance Sheet

Feb 12
GoodRx Holdings (NASDAQ:GDRX) Has A Rock Solid Balance Sheet

GoodRx: Cost Saving Is A Strong Value Proposition To Consumers

Jan 23

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Jan 22
GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

GoodRx Stock Spikes After Receiving A Strong Dose Of Performance

Jan 11

What Is GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Share Price Doing?

Dec 02
What Is GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Share Price Doing?

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Sep 12
GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

An Intrinsic Calculation For GoodRx Holdings, Inc. (NASDAQ:GDRX) Suggests It's 41% Undervalued

Jul 14
An Intrinsic Calculation For GoodRx Holdings, Inc. (NASDAQ:GDRX) Suggests It's 41% Undervalued

GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

May 27
GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

Some Confidence Is Lacking In GoodRx Holdings, Inc. (NASDAQ:GDRX) As Shares Slide 27%

May 05
Some Confidence Is Lacking In GoodRx Holdings, Inc. (NASDAQ:GDRX) As Shares Slide 27%

Investors Give GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares A 27% Hiding

May 05
Investors Give GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares A 27% Hiding

Is There An Opportunity With GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 45% Undervaluation?

Mar 23
Is There An Opportunity With GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 45% Undervaluation?

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Feb 07
GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

CEO 보상 분석

Scott Wagner 의 보수는 GoodRx Holdings 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

-US$16m

Jun 30 2024n/an/a

-US$59m

Mar 31 2024n/an/a

-US$7m

Dec 31 2023US$10mUS$512k

-US$9m

보상 대 시장: Scott 의 총 보상 ($USD 10.14M )은 US 시장( $USD 5.38M ).

보상과 수익: Scott 의 보상을 회사 성과와 비교하기에는 데이터가 부족합니다.

CEO

Scott Wagner (53 yo)

1.6yrs

테뉴어

US$10,144,526

보상

Mr. Scott W. Wagner serves as Interim Chief Executive Officer at GoodRx Holdings, Inc. since April 25, 2023 and serves as its Principal Operating Officer since February 15, 2024. He serves as Head of Strat...

리더십 팀

이름위치테뉴어보상소유권
Trevor Bezdek
Co-founder & Chairman of the Board13.2yrsUS$811.53k1.4%
$ 22.9m
Scott Wagner
Interim CEO & Principal Operating Officer1.6yrsUS$10.14m0.11%
$ 1.9m
Douglas Hirsch
Co-founder13.2yrsUS$784.86k1.4%
$ 22.9m
Karsten Voermann
Chief Financial Officer4.7yrsUS$902.24k0.071%
$ 1.2m
Romin Nabiey
Chief Accounting Officer2.6yrsUS$2.58m0.021%
$ 349.6k
Bansi Nagji
President of Healthcare4.4yrsUS$4.91m0.065%
$ 1.1m
Mike Walsh
President & Executive VP of Prescription Marketplaceless than a year데이터 없음데이터 없음
Nitin Shingate
Chief Technology Officer1.9yrs데이터 없음데이터 없음
Aubrey Reynolds
Director of Investor Relationsno data데이터 없음데이터 없음
Gracye Cheng
General Counsel & Secretaryno data데이터 없음데이터 없음
Andrew Slutsky
Chief Marketing Officer1.3yrsUS$864.80k데이터 없음
Vina Leite
Chief People Officer2.5yrs데이터 없음데이터 없음

2.5yrs

평균 재임 기간

53yo

평균 연령

경험이 풍부한 관리: GDRX 의 관리팀은 경험 ( 2.5 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Trevor Bezdek
Co-founder & Chairman of the Board13.2yrsUS$811.53k1.4%
$ 22.9m
Douglas Hirsch
Co-founder13.2yrsUS$784.86k1.4%
$ 22.9m
Gregory Mondre
Independent Director6.1yrs데이터 없음데이터 없음
Dipanjan Deb
Independent Director9.1yrs데이터 없음데이터 없음
Ian T. Clark
Directorless than a year데이터 없음데이터 없음
Agnes Rey-Giraud
Independent Director8.4yrsUS$269.53k0.078%
$ 1.3m
Christopher Adams
Independent Director9.1yrs데이터 없음데이터 없음
Simon Patterson
Directorless than a year데이터 없음데이터 없음
Kelly Kennedy
Independent Directorless than a yearUS$448.63k데이터 없음
Ronald Bruehlman
Directorno data데이터 없음0.0056%
$ 91.7k

7.3yrs

평균 재임 기간

54yo

평균 연령

경험이 풍부한 이사회: GDRX 의 이사회는 경험(평균 재직 기간 7.3 년)으로 간주됩니다.